0001140361-15-041198.txt : 20151113
0001140361-15-041198.hdr.sgml : 20151113
20151113164954
ACCESSION NUMBER: 0001140361-15-041198
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151111
FILED AS OF DATE: 20151113
DATE AS OF CHANGE: 20151113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Labinger Barry
CENTRAL INDEX KEY: 0001332456
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 151229818
MAIL ADDRESS:
STREET 1: 6791 BRENDAN COURT
CITY: EDINA
STATE: MN
ZIP: 55439
4
1
doc1.xml
FORM 4
X0306
4
2015-11-11
0
0001367644
Emergent BioSolutions Inc.
EBS
0001332456
Labinger Barry
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Biosciences Div.
Common Stock
2015-11-11
4
S
0
6564
35.51
D
30229
D
Common Stock
2015-11-11
4
M
0
9373
28.09
A
39602
D
Common Stock
2015-11-11
4
S
0
9373
35.50
D
30229
D
Common Stock
2015-11-11
4
M
0
10095
20.94
A
40324
D
Common Stock
2015-11-11
4
S
0
10095
35.50
D
30229
D
Common Stock
2015-11-12
4
M
0
10094
20.94
A
40323
D
Common Stock
2015-11-12
4
S
0
10094
36
D
30229
D
Common Stock
2015-11-11
4
F
0
1671
35.88
D
28558
D
Stock Option
28.09
2015-11-11
4
M
0
9373
0
D
2014-03-11
2021-03-10
Common Stock
9373
0
D
Stock Option
20.94
2015-11-11
4
M
0
10095
0
D
2013-11-11
2020-11-11
Common Stock
10095
0
D
Stock Option
20.94
2015-11-12
4
M
0
10094
0
D
2013-11-11
2020-11-11
Common Stock
10094
0
D
Consists of an option granted under the company's stock incentive plan on March 11, 2014.
Consists of an option granted under the company's stock incentive plan on November 12, 2013.
Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50-$35.59, inclusive.
/s/ Eric Burt, attorney-in-fact
2015-11-13